Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration: A Large-Scale Clinical Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07725900
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-07-25T00:09:29.036510+00:00
Published At
2026-07-24T00:00:00+00:00
Record Updated At
2026-07-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hyperpigmentation", "Dry Skin", "Erythema"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-07-24"
protocolSection.identificationModule.nctId
"NCT07725900"
protocolSection.identificationModule.officialTitle
"Clinical Efficacy and Safety of MB Luxury\u24c7 Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration: A Large-Scale Clinical Trial"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hyperpigmentation (protocolSection.conditionsModule.conditions)
  • Dry Skin (protocolSection.conditionsModule.conditions)
  • Erythema (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.